Enveric Biosciences, Inc.
(NASDAQ : AMRH)

( )
AMRH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -1.84%46.300.0%$196.99m
VRXValeant Pharmaceuticals International, Inc. -0.04%28.5214.1%$167.82m
HZNPHorizon Therapeutics Plc 0.00%116.015.5%$139.52m
ICLRICON plc 0.00%285.142.8%$113.50m
CTLTCatalent, Inc. 0.05%133.582.0%$95.76m
JAZZJazz Pharmaceuticals Plc 0.00%137.372.1%$78.89m
PRGOPerrigo Co. Plc 0.63%44.686.9%$71.33m
UTHRUnited Therapeutics Corp. 0.00%190.4514.0%$71.32m
ARGXargenx SE 0.00%281.850.0%$39.33m
GRVIGrove, Inc. 4.55%5.980.0%$37.66m
AXSMAxsome Therapeutics, Inc. 0.00%39.691.8%$36.14m
PCRXPacira Biosciences, Inc. 0.00%52.419.8%$31.18m
BHCBausch Health Cos., Inc. -0.04%28.520.0%$30.38m
RVNCRevance Therapeutics, Inc. 0.00%14.016.1%$29.90m
ENDPEndo International Plc 0.00%4.388.5%$28.37m

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.